208 related articles for article (PubMed ID: 35164638)
1. Survival benefit of thermal ablation combined with chemotherapy for the treatment of stage IV nonsmall cell lung cancer: a propensity-matched analysis.
Yang H; Li M; Mei T
Int J Hyperthermia; 2022; 39(1):348-357. PubMed ID: 35164638
[TBL] [Abstract][Full Text] [Related]
2. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
3. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
4. Clinical efficacy of thermal ablation for the treatment of pulmonary carcinoid tumor: a propensity-matched analysis.
Yang H; Li M; Liu T; Luo L
Int J Hyperthermia; 2023; 40(1):2225817. PubMed ID: 37364893
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis.
Yang WY; He Y; Hu Q; Peng M; Zhang Z; Xie S; Yu F
Front Oncol; 2022; 12():984932. PubMed ID: 36081544
[TBL] [Abstract][Full Text] [Related]
7. Lobectomy versus segmentectomy in patients with stage T (> 2 cm and ≤ 3 cm) N0M0 non-small cell lung cancer: a propensity score matching study.
Wang L; Ge L; You S; Liu Y; Ren Y
J Cardiothorac Surg; 2022 May; 17(1):110. PubMed ID: 35545793
[TBL] [Abstract][Full Text] [Related]
8. Surgical outcomes for non-small cell lung cancer in younger adults: A population-based study.
Zhang Z; Huo H; Li F; Miao J; Hu B; Chen S
Thorac Cancer; 2024 May; 15(15):1218-1227. PubMed ID: 38606839
[TBL] [Abstract][Full Text] [Related]
9. Thermal ablation versus radiotherapy for inoperable stage III non-small cell lung cancer: a propensity score matching analysis.
Yang WY; He Y; Peng M; Zhang Z; Xie S; Wu Z; Hu Q; Yu F
Int J Hyperthermia; 2023; 40(1):2154577. PubMed ID: 36535924
[TBL] [Abstract][Full Text] [Related]
10. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
Gao L; Shen L; Wang K; Lu S
Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
[TBL] [Abstract][Full Text] [Related]
11. Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database.
Moreno AC; Morgensztern D; Yu JB; Boffa DJ; Decker RH; Detterbeck FC; Kim AW
J Surg Res; 2013 Sep; 184(1):10-8. PubMed ID: 23583079
[TBL] [Abstract][Full Text] [Related]
12. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
Ren Y; Dai C; Shen J; Liu Y; Xie D; Zheng H; He J; Liang W; Jiang G; Fei K; Yang P; He J; Chen C
Oncotarget; 2016 May; 7(18):26856-65. PubMed ID: 27057627
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of local thoracic surgery in patients with stage IV non-small-cell lung cancer: A SEER-based analysis.
Jia J; Guo B; Yang Z; Liu Y; Ga L; Xing G; Zhang S; Jin A; Ma R; Wang J
Eur J Cancer; 2021 Feb; 144():326-340. PubMed ID: 33388490
[TBL] [Abstract][Full Text] [Related]
14. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
Wu L; Zhao W; Chen T; Yang Y
J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
[TBL] [Abstract][Full Text] [Related]
15. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
Moon MH; Moon YK; Moon SW
Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
[TBL] [Abstract][Full Text] [Related]
16. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
[TBL] [Abstract][Full Text] [Related]
17. Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patients.
Berry MF; Coleman BK; Curtis LH; Worni M; D'Amico TA; Akushevich I
Ann Surg Oncol; 2015 Feb; 22(2):642-8. PubMed ID: 25192680
[TBL] [Abstract][Full Text] [Related]
18. Surgery versus radiotherapy in octogenarians with stage Ia non‑small cell lung cancer: propensity score matching analysis of the SEER database.
Ni L; Lin G; Zhang Z; Sun D; Liu Z; Liu X
BMC Pulm Med; 2022 Nov; 22(1):411. PubMed ID: 36357868
[TBL] [Abstract][Full Text] [Related]
19. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
20. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
